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COMPETITION IN HEALTHCARE
Two issues with competition in healthcare
Lucy A Reynolds research fellow
London School of Hygiene and Tropical Medicine, London WC1E 7HT, UK
Two issues are important in any discussion of competition in
healthcare.
Firstly, while “any qualified provider” (AQP) now replaces
“any willing provider” (AWP), comparison of the mid-2010
Department of Health procurement guidance with this month’s
NHS Confederation advice shows that their commissioning
processes are identical.1 Themarket based AWP commissioning
process conforms to EU public procurement regulations. “AQP”
is meaningless in EU law, so the AWP process has merely been
renamed, with no new qualification procedure.
Secondly, the current NHS reform was delineated in 1987-8, in
papers by MPs Redwood, Letwin (both ex-directors of
Rothschilds’ Privatisation Unit), Willetts, and Peet. All asserted
without evidence that competition would benefit UK healthcare.
In 2005, Lansley proclaimed “maximising competition” as the
“principle of NHS reform,”2 and now he prescribes competition
for every NHS ill.
But 24 years after such reforms were designed, supporters can
justify them only by citing a few recent observational studies
claiming that competition improves health outcomes, although
confounding may explain these effects.3
Competition based reform involves activity based fees for
service (misnamed “payment by results”). Financial incentives
raise doctors’ activity levels,4 but this does not translate into
better health outcomes. If doctors paid this way are
underprovided in a community, more activity might improve
outcomes. If they are overprovided (hence, competition exists),
their need to make a living incentivises overtreatment.5 No
treatment is devoid of adverse effects, so poorer outcomes
ensue.6 Using fees for service generates undertreatment and
overtreatment, with efforts diverted away from people inmedical
need who cannot pay towards those who can pay but don’t
necessarily need treatment.
Welfare economics provides the theoretical justification for
promoting competition, but this model doesn’t fit healthcare.
Themain problem is information asymmetry: because the patient
consults the doctor for advice and accepts the treatment
recommended, the supplier controls demand. Combining
information asymmetry with fees for service generates supplier
induced demand, a phenomenon that absorbed 10-12% of 2009
US healthcare spending.7This phenomenon disproves the theory
that patient choice in a competitive healthcare market limits
costs and raises quality.
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